ROIV
Roivant Sciences Ltd

1,971
Mkt Cap
$15.98B
Volume
1,489.00
52W High
$23.91
52W Low
$8.73
PE Ratio
-41.59
ROIV Fundamentals
Price
$22.98
Prev Close
$23.13
Open
$22.73
50D MA
$21.49
Beta
0.81
Avg. Volume
8.08M
EPS (Annual)
-$0.2371
P/B
3.63
Rev/Employee
$38,737.33
Loading...
Loading...
News
all
press releases
Eric Venker Sells 200,000 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 12th. The stock was sold at an...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 12th. The shares were sold at an...
MarketBeat·7d ago
News Placeholder
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Brokerages
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) has received an average rating of "Moderate Buy" from the ten analysts that are covering the company, Marketbeat reports. Two investment analysts...
MarketBeat·16d ago
News Placeholder
Penn Davis Mcfarland Inc. Buys 170,456 Shares of Roivant Sciences Ltd. $ROIV
Penn Davis Mcfarland Inc. boosted its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 10.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·17d ago
News Placeholder
Pacer Advisors Inc. Makes New Investment in Roivant Sciences Ltd. $ROIV
Pacer Advisors Inc. acquired a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·18d ago
News Placeholder
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Insider Sells 311,873 Shares of Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 311,873 shares of the company's stock in a transaction that occurred on Monday, December 29th. The shares were sold...
MarketBeat·20d ago
News Placeholder
Mayukh Sukhatme Sells 1,018,995 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 1,018,995 shares of the company's stock in a transaction that occurred on Wednesday, December 31st. The shares were...
MarketBeat·21d ago
News Placeholder
Mayukh Sukhatme Sells 311,873 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 311,873 shares of Roivant Sciences stock in a transaction on Monday, December 29th. The shares were sold at an...
MarketBeat·21d ago
News Placeholder
Short Interest in Roivant Sciences Ltd. (NASDAQ:ROIV) Drops By 16.2%
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling...
MarketBeat·21d ago
News Placeholder
Richard Pulik Sells 406,731 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CFO Richard Pulik sold 406,731 shares of Roivant Sciences stock in a transaction on Tuesday, December 23rd. The stock was sold at an average...
MarketBeat·23d ago
<
1
2
...
>

Latest ROIV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.